Gene expression by human monocytes from peripheral blood in response to exposure to metals

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 76, Issue 2, 2006, Pages 449-455

  Jost Albrecht, Katrin ^a   Hofstetter, Willy ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Arthroplasty; Aseptic loosening; Bone resorption; Cytokine; Gene expression; Inflammation; Monocyte

Indexed keywords

BLOOD; COMPOSITION; IMPLANTS (SURGICAL); LANTHANUM COMPOUNDS; NICKEL; POSITIVE IONS; TITANIUM;

ARTHROPLASTY; ASEPTIC LOOSENING; BONE RESORPTION; MONOCYTE;

GENES;

ALLOY; CALCIUM ANTAGONIST; COBALT; CYTOKINE; LANTHANUM CHLORIDE; METAL; NICKEL; TITANIUM;

ARTHROPLASTY; ARTICLE; CHEMICAL COMPOSITION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMPLANT; INFLAMMATION; LIFE EXPECTANCY; LIFESTYLE; LONGEVITY; MONOCYTE; OSTEOLYSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PROSTHESIS LOOSENING; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION;

ALLOYS; ARTHROPLASTY; CATIONS, DIVALENT; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; METALS; MONOCYTES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 31544483914     PISSN: 00219304     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.30389     Document Type: Article

References (27)

1. Willert HG, Buchhorn GH, Gobel D, Koster G, Schaffner S, Schenk R, Semlitsch M. Wear behavior and histopathology of classic cemented metal on metal hip endoprostheses. Clin Orthop 1996;329:S160-S186.
2. Hallab NJ, Mikecz K, Vermes C, Skipor A, Jacobs JJ. Differential lymphocyte reactivity to serum-derived metal-protein complexes produced from cobalt-based and titanium-based implant alloy degradation. J Biomed Mater Res 2001;56:427-436.
3. Hallab NJ, Mikecz K, Vermes C, Skipor A, Jacobs JJ. Orthopaedic implant related metal toxicity in terms of human lymphocyte reactivity to metal-protein complexes produced from cobalt-base and titanium-base implant alloy degradation. Mol Cell Biochem 2001;222:127-136.
4. Wooley PH, Nasser S, Fitzgerald RH. The immune response to implant materials in humans. Clin Orthop 1996;326:63-70.
5. Ingham E, Fisher J. Biological reactions to wear debris in total joint replacement. Proc Inst Mech Eng [H] 2000;214:21-37.
6. Hallab N, Merritt K, Jacobs JJ. Metal sensitivity in patients with orthopaedic implants. J Bone Joint Surg Am 2001;83A:428-436.
7. Menne T, Christophersen J. Epidemiology of allergic contact sensitization. Curr Probl Dermatol 1985;14:1-30.
8. Thewes M, Kretschmer R, Gfesser M, Rakoski J, Nerlich M, Borelli S, Ring J. Immunohistochemical characterization of the perivascular infiltrate cells in tissues adjacent to stainless steel implants compared with titanium implants. Arch Orthop Trauma Surg 2001;121:223-226.
9. Savarino L, Granchi D, Ciapetti G, Cenni E, Nardi Pantoli A, Rotini R, Veronesi CA, Baldini N, Giunti A. Ion release in patients with metal-on-metal hip bearings in total joint replacement: a comparison with metal-on-polyethylene bearings. J Biomed Mater Res 2002;63:467-474.
10. Blaine TA, Rosier RN, Puzas JE, Looney RJ, Reynolds PR, Reynolds SD, O'Keefe RJ. Increased levels of tumor necrosis factor-alpha and interleukin-6 protein and messenger RNA in human peripheral blood monocytes due to titanium particles. J Bone Joint Surg Am 1996;78:1181-1192.
11. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002;3:RESEARCH0034.
12. Heinemann DEH, Peters JH, Willert GH. Die Rolle von Monozyten und Makrophagen bei der Gewebereaktion auf Verschleissprodukte orthopaedischer Implantatwerkstoffe. Osteologie 1997;6:112-224.
13. Kwan Tat S, Padrines M, Theoleyre S, Heymann D, Fortun Y. IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev 2004;15: 49-60.
14. Purton LE, Lee MY, Torok-Storb B. Normal human peripheral blood mononuclear cells mobilized with granulocyte colony-stimulating factor have increased osteoclastogenic potential compared to nonmobilized blood. Blood 1996;87:1802-1808.
15. Hattersley G, Chambers TJ. Effects of interleukin 3 and of granulocyte-macrophage and macrophage colony stimulating factors on osteoclast differentiation from mouse hemopoietic tissue. J Cell Physiol 1990;142:201-209.
16. Felix R, Cecchini MG, Hofstetter W, Elford PR, Stutzer A, Fleisch H. Impairment of macrophage colony-stimulating factor production and lack of resident bone marrow macrophages in the osteopetrotic op/op mouse. J Bone Miner Res 1990;5:781-789.
17. Miyanishi K, Trindade MC, Ma T, Goodman SB, Schurman DJ, Smith RL. Periprosthetic osteolysis: induction of vascular endothelial growth factor from human monocyte/macrophages by orthopaedic biomaterial particles. J Bone Miner Res 2003;18: 1573-1583.
18. Engsig MT, Chen QJ, Vu TH, Pedersen AC, Therkidsen B, Lund LR, Henriksen K, Lenhard T, Foged NT, Werb Z, Delaisse JM. Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J Cell Biol 2000;151:879-889.
19. Henriksen K, Karsdal M, Delaisse JM, Engsig MT. RANKL and vascular endothelial growth factor (VEGF) induce osteoclast chemotaxis through an ERK1/2-dependent mechanism. J Biol Chem 2003;278:48745-48753.
20. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T. Osteoclast differentiation factor is a ligand for osteoprotegerin osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 1998;95:3597-3602.
21. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang M-S, Lüthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan H-L, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee RAEP, Boyle WJ. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997;89:309-319.
22. Khosla S. Minireview: the OPG/RANKL/RANK system. Endocrinology 2001;142:5050-5055.
23. Bendre MS, Montague DC, Peery T, Akel NS, Gaddy D, Suva LJ. Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease. Bone 2003;33:28-37.
24. Gaddy-Kurten D, Coker JK, Abe E, Jilka RL, Manolagas SC. Inhibin suppresses and activin stimulates osteoblastogenesis and osteoclastogenesis in murine bone marrow cultures. Endocrinology 2002;143:74-83.
25. Barton BE, Mayer R. IL-3 induces differentiation of bone marrow precursor cells to osteoclast-like cells. J Immunol 1989; 143:3211-3216.
26. Bizzarri C, Shioi A, Teitelbaum SL, Ohara J, Harwalkar VA, Erdmann JM, Lacey DL, Civitelli R. Interleukin-4 inhibits bone resorption and acutely increases cytosolic Ca2+ in murine osteoclasts. J Biol Chem 1994;269:13817- 13824.
27. Hallab NJ, Mikecz K, Vermes C, Skipor A, Jacobs JJ. Orthopaedic implant related metal toxicity in terms of human lymphocyte reactivity to metal-protein complexes produced from cobalt-base and titanium-base implant alloy degradation. Mol Cell Biochem 2001;222:127-136.